www.fdanews.com/articles/156958-roche-halts-investigation-of-aleglitazar-following-regular-safety-review-of-phase-iii-trial
Roche Halts Investigation of Aleglitazar Following Regular Safety Review of Phase III Trial
July 10, 2013
Roche has discontinued its trial of aleglitazar, called AleCardio, due to safety problems and lack of efficacy.
Roche
Roche